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Letters to the Editoridentified. Compression of the left coro-
nary system by this expanding cavity
was also demonstrated with 3-dimen-
sional magnetic resonance imaging. An
open cardiac operation with a Dacron
patch was performed without any com-
plication.
Pseudoaneurysm formation in the
MAIVF is a rarely seen pathologic
condition. Acquired causes are the
most common,1-3 although MAIVF
aneurysm can be congenital in origin.4
Infective endocarditis followed by iat-
rogenic causes is the most common
among acquired etiologies. Cases are
generally asymptomatic. The patho-
logic condition has generally been de-
tected during routine evaluation or at
autopsy. The most probable patho-
physiologic mechanism is avascular
nature of the tissue with insufficient
compliance and healing causing
balloon-type dilatation and pseudoa-
neurysm formation. For the diagnosis,
noninvasive imaging tools are the first
line. Conventional 2-dimensional
echocardiograms with Doppler study,
either transthoracic or transesopha-
geal, are the initial diagnostic tools.
However, limited spatial resolution
restricts their usefulness. Real-time
multiplane/3-dimensional echocardi-
ography and computed tomographic
angiography/contrast-enhanced mag-
netic resonance imaging are the
methods supplying higher spatial/
temporal resolution and more detailed
anatomic relations.2,4 Medical follow-
up, percutenous intervention, and
surgery are the treatment modalities.5
In conclusion, this rare anomaly
should be kept in mind when a dilata-
tion is seen in the para-aortic region,
especially after infective endocarditis
and valve surgery.
Serkan Cay, MD
Department of Cardiology
Yuksek Ihtisas Heart–Education and
Research Hospital
Ankara, Turkey
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To the Editor:
We read with great interest the reply
byBenedetto and colleagues1 to our let-
ter,2 in which we challenged the inclu-
sion of Gaudino and associates’3 data
in a meta-analysis (controlled, random-
ized trials comparing the angiographic
patency of radial artery [RA] versus sa-
phenous vein grafts [SVGs]) by Bene-
detto and coauthors4 that was recently
published in the Journal. In their reply,
we were criticized for misrepresenta-
tion of the data from Gaudino and
colleagues’ article3 included in their
meta-analysis.4 The article by Gaudino
and colleagues3 reported 2 controlled,
randomized trials including patients
with previous percutaneous stent im-
plantation (in any coronary vessel)
with preoperative angiographic confir-
mation of a failed (trial I) or patent (trial
II) intracoronary stent. As the authors
stated,1 for the purpose of their meta-
analysis they included only Gaudino
and colleagues’ data3 on conduits ran-
domly assigned to targeted obtuse mar-
ginal (OM) branches of the circumflex
artery. Therefore, they stated that the
Gaudino I study3 included RA versus
SVG conduits randomly grafted to pre-
viously stented OM branches, and that
the Gaudino II study3 included RA ver-ardiovascular Surgery c September 201sus SVG conduits grafted to unstented
OM branches.
Gaudino and colleagues3 reported
that a study inclusion criterion was
previous percutaneous coronary angio-
plasty with successful stent implanta-
tion in any coronary vessel at least 1
month before surgery. Although there
were no data on stent location, we do
not know how Benedetto and col-
leagues1 concluded that 60 failed stents
were located in targeted OM branches
in the Gaudino I study (20 OM
branches grafted with RAs, 20 OM
branches grafted with SVGs, and 20
OM branches grafted with right inter-
nal thoracic artery), as they suggested
in their reply.1 In our opinion, the dis-
tribution of compared grafts regarding
the stent location in theGaudino I study
definitely was not defined. For Gau-
dino and colleagues,3 in-stent resteno-
sis and graft failure are markers of
aggressive coronary atherosclerosis.
For us, they could be a pathophysio-
logic response to the presence of an in-
travascular foreign body (stent) that
may adversely affect the fate of the
conduits used to graft stented coronary
arteries. That was the reason we men-
tioned a subsequent analysis5 of Gau-
dino and colleagues’ initial report,3 in
which the authors concluded that pa-
tients in whom in-stent restenosis de-
veloped have a higher risk of early
venous graft failure. Even in that arti-
cle, there were no precise data about
the number of failed RAs or SVGs
that were distributed to targeted coro-
nary arteries with in-stent restenosis.
Although 45 grafts were placed distal
to a failed stent, it is possible that the
majority of venous grafts were placed
on previously stented coronary arteries.
Although we do not know the distri-
bution of occluded conduits regarding
the stent locations in the Gaudino I
study, we cannot definitively state
the reasons that influenced the graft
patency. Thus, we do not support the
inclusion of the Gaudino I study in
the meta-analysis we have discussed.
We do agree that we have made a
mistake asking for exclusion of the0
Letters to the EditorGaudino II study from the aforemen-
tioned meta-analysis.
Dusko Nezic, MD, PhD, FETCS
Aleksandar Knezevic, MD, BcS
Petar Vukovic, MD, BcS
‘‘Dedinje’’ Cardiovascular Institute
Belgrade, SerbiaReferences
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STRICTURE
To the Editor:
It was a pleasure reading the article
by Mercy George and colleagues in
the Journal.1 I would like to note that
the technique for treating benign sub-
glottic stricture on pages 414 and 415FIGURE 1. Temporary plastic obturator in upper tr
permission.2,3
The Journalof their article was described in previ-
ously published studies.2,3
Figure 1 is a copy of the illustration
used in my article.
Nicholas J. Demos, MD, PA
Jersey City, New JerseyReferences
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We thank Dr Demos for his com-
ment on our article on the management
of pediatric subglottic stenosis with
glottis involvement.
The management of glotto-subglot-
tic stenosis is challenging, and its
surgical management, therefore, has
evolved over the years with descrip-
tions of the surgical technique and its
modifications, along with the use of
stents. The technique we have used in
this large pediatric series is different
from that described earlier by Demos
and colleagues in 1969.1,2 Notably,
this series is the first pediatric
series of its kind. The technique com-
bines a subglottic resection and thyro-achia and glottis fixed with wire. Reprinted with
of Thoracic and Cardiovascular Surgetracheal anastomosis with a posterior
cricoid split and costal cartilage graft
for glotto-subglottic stenoses. This op-
eration was named ‘‘extended partial
cricotracheal resection.’’ The LT-
Mold prosthesis is also different in
that it calibrates the supraglottic and
glottic spaces in the abducted position
of the vocal cords, while restoring a tri-
angular shape to the glottis with a sharp
anterior laryngeal commissure.3 All
currently available stents are round
or cigar shaped and do not restore a tri-
angular glottis, especially in the case of
vocal cord synechia or grade IV trans-
glottic stenosis. The use of the LT-
Mold prosthesis has significantly
diminished the incidence of postopera-
tive granulations that require repeat
endoscopic/open procedures. This
study was therefore a synthesis of our
experience of complex pediatric
glotto-subglottic stenosis that docu-
ments the evolution of the technique
with an emphasis on the silicone
LT-Mold.
Mercy George, MS
Philippe Monnier, MD
Department of Otorhinolaryngology
Head and Neck Surgery
University Hospital
Lausanne, Switzerland
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SURGERY
To the Editor:
What is the future of cardiac surgery?
This question undoubtedly brings to
mind images of fancy new technology,
robots, stents, lasers, and other mini-
mally invasive or futuristic techniques.ry c Volume 140, Number 3 723
